The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Share News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.25
Bid: 24.00
Ask: 24.50
Change: -1.00 (-3.96%)
Spread: 0.50 (2.083%)
Open: 25.25
High: 25.25
Low: 24.25
Prev. Close: 25.25
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: Mitchells & Butlers Down Amid Raise Plan

Thu, 07th Jan 2021 10:51

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.

----------

FTSE 100 - WINNERS

----------

J Sainsbury, up 3.8%. The grocer's like-for-like sales in the nine weeks to January 2 - so including the key festive period - were up 9.3% year-on-year. For the whole of its third-quarter, like-for-like sales, excluding fuel, climbed 8.6%. Including fuel, like-for-like sales were up a more modest 3.2%.

----------

FTSE 100 - LOSERS

----------

Experian, down 2.4%. The stock went ex-dividend, meaning new buyers no longer qualify for the latest payout.

----------

FTSE 250 - LOSERS

----------

Trainline, down 7.8%. Launched an offering of GBP150 million of senior unsecured convertible bonds due 2026. The train booking platform operator in UK said the net proceeds of the five-year bonds will "provide additional liquidity, protecting the business further in an extended Covid downturn".

----------

Mitchells & Butlers, down 7.0%. Reports sharp 67% sales fall for 14 weeks to January 2 and adds that it is mulling an equity raise.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

Sareum Holdings, up 10%. The Cambridge-based drug developer said the US Patent Office approved its patent application for an invention associated with its SDC-1802 TYK2/JAK1 kinase inhibitor programme

----------

James Fisher & Sons, up 7.9%. The marine services provider saw improved trading in its fourth quarter, so now expects 2020 underlying profit to be at the upper end of its guided range.

----------

Synectics, up 4.9%. The Sheffield, England-based provider of security systems has successfully deployed the first phase of its operational management system for German railway operator S-Bahn in Berlin.

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

Ormonde Mining, down 29%. Adjourns annual general meeting scheduled for Thursday. The Spain-focused natural resources firm says this is so it can continue talks with its largest shareholder over motions six to eight, concerning its share capital and ability to make market purchases.

----------

Joules Group, down 6.1%. The retailer said sales in the seven months trading period to January 3 were better than expected, though in-store sales in the seven weeks to January 3 plunged 58%.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
23 Apr 2021 12:17

Sareum shares rise after improved interim results, research progress

Sareum shares rise after improved interim results, research progress

Read more
16 Feb 2021 13:56

IN BRIEF: Sareum Notes Launch Of UK Government's Agile Platform

IN BRIEF: Sareum Notes Launch Of UK Government's Agile Platform

Read more
7 Jan 2021 12:52

Sareum gets approval for US patent application

(Sharecast News) - Specialist drug development company Sareum announced on Thursday that the United States Patent and Trademark Office has now formally approved its patent application, number 16/351,620.

Read more
7 Jan 2021 09:53

Sareum Shares Rise On Granting Of Patent For SDC-1802 Inhibitor

Sareum Shares Rise On Granting Of Patent For SDC-1802 Inhibitor

Read more
16 Dec 2020 22:00

IN BRIEF: Sareum Makes Progress On Potential Covid Treatment Candidate

IN BRIEF: Sareum Makes Progress On Potential Covid Treatment Candidate

Read more
14 Dec 2020 12:27

Sareum Shares Surge 30% After Study Results Support Covid-19 Programme

Sareum Shares Surge 30% After Study Results Support Covid-19 Programme

Read more
8 Dec 2020 15:51

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
3 Dec 2020 15:45

IN BRIEF: Sareum Gets GBP174,000 To Research Potential Virus Treatment

IN BRIEF: Sareum Gets GBP174,000 To Research Potential Virus Treatment

Read more
3 Dec 2020 12:19

Sareum Holdings secures grant for Covid-19 treatment project

(Sharecast News) - Specialist drug development company Sareum Holdings announced on Thursday that the grant offer letter from UK Research and Innovation (UKRI) had now been received and approved.

Read more
12 Nov 2020 19:17

UK TRADING UPDATE SUMMARY: Clipper Expects 20% Interim Revenue Climb

UK TRADING UPDATE SUMMARY: Clipper Expects 20% Interim Revenue Climb

Read more
27 Oct 2020 15:16

IN BRIEF: Sareum Nets Covid-19 Therapy UK Research Grant

IN BRIEF: Sareum Nets Covid-19 Therapy UK Research Grant

Read more
13 Oct 2020 13:54

IN BRIEF: Sareum Loss Narrows On Reduced Administration Expenses

IN BRIEF: Sareum Loss Narrows On Reduced Administration Expenses

Read more
8 Oct 2020 19:54

UK TRADING UPDATE SUMMARY: Motorpoint Predicts Local Lockdowns Bite

UK TRADING UPDATE SUMMARY: Motorpoint Predicts Local Lockdowns Bite

Read more
8 Oct 2020 15:50

Sareum to get US patent on SDC-1802 programme

(Sharecast News) - Specialist drug development company Sareum announced on Thursday that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance for a patent on an invention associated with its proprietary 'SDC-1802 TYK2/JAK1 Kinase Inhibitor Programme'.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.